South Korea Companion Animal Vaccines Market Size, Share, and COVID-19 Impact Analysis, By Animal Type (Canine and Feline), By Product (Attenuated Live Vaccines and Recombinant Vaccine), By Route of Administration (Subcutaneous, Intramuscular, and Intranasal), By Distribution Channel (Hospital/Clinic Pharmacy and E-Commerce), and South Korea Companion Animal Vaccines Market Insights, Industry Trend, Forecasts to 2035

  South Korea Companion Animal Vaccines Market Insights Forecasts to 2035

• The South Korea Companion Animal Vaccines Market Size Was Estimated at USD 58.0 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 9.06% from 2025 to 2035
• The South Korea Companion Animal Vaccines Market Size is Expected to Reach USD 150.6 Million by 2035

According to a research report published by Spherical Insights & Consulting, the South Korea Companion Animal Vaccines Market is anticipated to reach USD 150.6 Million by 2035, growing at a CAGR of 9.06% from 2025 to 2035. Growing pet ownership, more knowledge of pet health, and the rise in infectious illness prevalence are the main factors propelling the market.

Market Overview

The development, manufacturing, and distribution of vaccines intended to shield domesticated animals mostly pets like cats and dogs from infectious diseases are all included in the companion animal vaccines market. By lowering the frequency and severity of illnesses and improving the general health and well-being of companion animals, these vaccinations are an essential component of preventative veterinary treatment. Pets that receive vaccinations are shielded from a variety of illnesses, leading to healthier and more active lifestyles. Vaccinating against diseases can greatly reduce the need for costly treatments in the future. The demand for vaccines is the growing number of companion animals, especially dogs and cats, around the region. More efficient and focused vaccination campaigns are presented by the creation of novel vaccine types, such as recombinant and DNA-based vaccines. Through grants and collaborations with private businesses and academic institutions, governments can finance the study and creation of novel and enhanced vaccines for companion animals. Governments occasionally start public awareness efforts to inform pet owners about the value of vaccinating their animals and providing them with preventative medical care. To increase access to immunizations and other medical services, governments may spend money on veterinary infrastructure, such as clinics and mobile pet care services.

Report Coverage

This research report categorizes the market for South Korea companion animal vaccines market based on various segments and regions forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea companion animal vaccines market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea companion animal vaccines market.

Driving Factors

Increasing awareness of animal health, and growing expenditure on veterinary care. Advances in vaccine technology, including DNA and recombinant vaccines, are enhancing efficacy and safety. The rising prevalence of zoonotic diseases further boosts the demand for immunization. Government initiatives and pet health regulations also support market growth. Additionally, the humanization of pets and demand for preventive healthcare among owners is accelerating the adoption of vaccines for dogs, cats, and other companion animals.

Restraining Factors

High costs of vaccine development and limited awareness in developing regions. Regulatory hurdles and lengthy approval processes can delay product launches. Additionally, vaccine storage and distribution challenges, especially in remote areas, hampered accessibility. Concerns about vaccine side effects and reluctance among pet owners also limit widespread adoption.

Market Segmentation

The South Korea companion animal vaccines market share is classified into animal type, product, route of administration, and distribution channel.

• The canine segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea companion animal vaccines market is segmented by animal type into canine and feline. Among these, the canine segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. The large population, rising adoption rates, and increasing healthcare awareness significantly contribute to the industry. The demand for canine vaccines is being driven by dog owners' increased propensity to vaccinate their pets against prevalent diseases like leptospirosis, parvovirus, rabies, and distemper.

• The attenuated live vaccines segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea companion animal vaccines market is segmented by product into attenuated live vaccines and recombinant vaccine. Among these, the attenuated live vaccines segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Vaccines are very efficient at preventing infectious diseases in dogs and cats because they use weakened microorganisms that elicit a powerful immune response without actually causing illness. Veterinarians and pet owners favor them because of their capacity to elicit humoral and cell-mediated immunity.

• The subcutaneous segment dominated share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea companion animal vaccines market is segmented by route of administration into subcutaneous, intramuscular, and intranasal. Among these, the subcutaneous segment dominated share in 2024 and is expected to grow at a significant CAGR during the forecast period. The great efficacy, low chance of negative responses, and simplicity of use. By administering vaccinations beneath the skin, this technique ensures an effective immune response while being less invasive than intramuscular injections.

• The hospital/clinic pharmacy segment held a majority share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea companion animal vaccines market is segmented by distribution channel into hospital/clinic pharmacy and e-commerce. Among these, the hospital/clinic pharmacy segment held a majority share in 2024 and is expected to grow at a significant CAGR during the forecast period. A large variety of vaccines are kept in stock by veterinary clinics and hospitals, allowing certified veterinarians to provide them on time, increasing demand and market expansion. To increase pet immunization rates, these clinics also frequently take part in educational efforts, public health initiatives, and collaborations with vaccine makers.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea companion animal vaccines market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• GC Biopharma (Green Cross Corporation)
• Chong Kun Dang Pharmaceutical Corp.
• Yuhan Corporation
• Celltrion, Inc.
• SK Bioscience Co., Ltd.
• Samsung Biologics Co., Ltd.
• Green Cross Veterinary Products Co., Ltd.
• ChoongAng Vaccine Laboratories Co., Ltd. (CAVAC)
• Korea Thumbvet Co., Ltd.
• Shinil Biogen Co., Ltd.
• DongKoo Bio & Pharma Co., Ltd.
• WooGene B&G Co., Ltd.
• Komipharm International Co., Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea companion animal vaccines market based on the below-mentioned segments:

 South Korea Companion Animal Vaccines Market, By Animal Type

• Canine
• Feline

South Korea Companion Animal Vaccines Market, By Product

• Attenuated Live Vaccines
• Recombinant Vaccine

South Korea Companion Animal Vaccines Market, By Route of Administration

• Subcutaneous
• Intramuscular
• Intranasal

South Korea Companion Animal Vaccines Market, By Distribution Channel

• Hospital/Clinic Pharmacy
• E-Commerce